Enhancing diversity of clinical trial populations in multiple sclerosis.

ABSTRACT:

Background

Demographic characteristics, social determinants of health (SDoH), health inequities, and health disparities substantially influence the general and disease-specific health outcomes of people with multiple sclerosis (MS). Participants in clinical trials do not represent all people with MS treated in practice.

Objective

To provide recommendations for enhancing diversity and inclusion in clinical trials in MS.

Methods

We held an international workshop under the Auspices of the International Advisory Committee on Clinical Trials in MS (the "Committee") to develop recommendations regarding diversity and inclusivity of participants of clinical trials in MS. Workshop attendees included members of the Committee as well as external participants. External participan

SUBMITTER: Marrie RA 

PROVIDER: S-EPMC10413791 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature